| Bioactivity | Retosiban (GSK221149A) is a potent and selective oxytocin antagonist with a Ki of 0.65 nM. | ||||||||||||
| Target | IC50: 0.65 nM (Oxytocin) | ||||||||||||
| Name | Retosiban | ||||||||||||
| CAS | 820957-38-8 | ||||||||||||
| Formula | C27H34N4O5 | ||||||||||||
| Molar Mass | 494.58 | ||||||||||||
| Appearance | Solid | ||||||||||||
| Transport | Room temperature in continental US; may vary elsewhere. | ||||||||||||
| Storage |
|
||||||||||||
| Reference | [1]. Liddle J, et al. The discovery of GSK221149A: a potent and selective oxytocin antagonist. Bioorg Med Chem Lett. 2008 Jan 1;18(1):90-4. |